RioTech Pharmaceuticals
London
About RioTech Pharmaceuticals
RioTech is an information site about Hepatitis C and the many forms of treatment and medication avaliable to those who suffer from it. Pharmasutical companies and reserchers from Oxford to California and all over the world are working to find better ways of treating and overcoming this virus. As it stands now, there is no here is no vaccine available to prevent HCV, and treatment for the stronger strain of the virus is only effective in treating it 50% of the time. However for those who are infected, there is some hope. Reserchers in the field of HCV treatment are beginging to understand more and more about Hepatitis C, and how to treat it. This website aims to relay this message to as many people as possible.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $1.6M
- Funding stage: Seed
- Last round: Seed (Nov 2005)
- Website: riotechpharma.com
Industries & Categories
Biotechnology, Health Care
Canonical: https://fsome.com/organization/riotech-pharmaceuticals-2705392 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.